Literature DB >> 31393853

Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles.

Tanyalak Parimon1, Changfu Yao1, David M Habiel1, Lingyin Ge1, Stephanie A Bora1, Rena Brauer1, Christopher M Evans2, Ting Xie1, Felix Alonso-Valenteen3, Lali K Medina-Kauwe3, Dianhua Jiang1, Paul W Noble1,3, Cory M Hogaboam1,3, Nan Deng4, Olivier Burgy2, Travis J Antes5, Melanie Königshoff2, Barry R Stripp1,3, Sina A Gharib6, Peter Chen1,3,4.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal lung disease. A maladaptive epithelium due to chronic injury is a prominent feature and contributor to pathogenic cellular communication in IPF. Recent data highlight the concept of a "reprogrammed" lung epithelium as critical in the development of lung fibrosis. Extracellular vesicles (EVs) are potent mediator of cellular crosstalk, and recent evidence supports their role in lung pathologies such as IPF. Here, we demonstrate that syndecan-1 is overexpressed by the epithelium in the lungs of IPF patients and in murine models after bleomycin injury. Moreover, we find that syndecan-1 is a pro-fibrotic signal that alters alveolar type II (ATII) cell phenotypes by augmenting TGFβ and Wnt signaling among other pro-fibrotic pathways. Importantly, we demonstrate that syndecan-1 controls the packaging of several anti-fibrotic microRNAs into EVs that have broad effects over several fibrogenic signaling networks as a mechanism of regulating epithelial plasticity and pulmonary fibrosis. Collectively, our work reveals new insight into how EVs orchestrate cellular signals that promote lung fibrosis and demonstrate the importance of syndecan-1 in coordinating these programs.

Entities:  

Keywords:  Fibrosis; Pulmonology

Mesh:

Substances:

Year:  2019        PMID: 31393853      PMCID: PMC6777916          DOI: 10.1172/jci.insight.129359

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  88 in total

1.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting.

Authors:  Laura Santangelo; Giorgio Giurato; Carla Cicchini; Claudia Montaldo; Carmine Mancone; Roberta Tarallo; Cecilia Battistelli; Tonino Alonzi; Alessandro Weisz; Marco Tripodi
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

2.  Syndecan defines precise spindle orientation by modulating Wnt signaling in C. elegans.

Authors:  Katsufumi Dejima; Sukryool Kang; Shohei Mitani; Pamela C Cosman; Andrew D Chisholm
Journal:  Development       Date:  2014-10-24       Impact factor: 6.868

3.  Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.

Authors:  Rena Brauer; Lingyin Ge; Saundra Y Schlesinger; Timothy P Birkland; Ying Huang; Tanyalak Parimon; Vivian Lee; Bonnie L McKinney; John K McGuire; William C Parks; Peter Chen
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

4.  Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.

Authors:  Kevin K Kim; Ying Wei; Charles Szekeres; Matthias C Kugler; Paul J Wolters; Marla L Hill; James A Frank; Alexis N Brumwell; Sarah E Wheeler; Jordan A Kreidberg; Harold A Chapman
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

5.  Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.

Authors:  Aina Martin-Medina; Mareike Lehmann; Olivier Burgy; Sarah Hermann; Hoeke A Baarsma; Darcy E Wagner; Martina M De Santis; Florian Ciolek; Thomas P Hofer; Marion Frankenberger; Michaela Aichler; Michael Lindner; Wolfgang Gesierich; Andreas Guenther; Axel Walch; Christina Coughlan; Paul Wolters; Joyce S Lee; Jürgen Behr; Melanie Königshoff
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

6.  Functional Wnt signaling is increased in idiopathic pulmonary fibrosis.

Authors:  Melanie Königshoff; Nisha Balsara; Eva-Maria Pfaff; Monika Kramer; Izabella Chrobak; Werner Seeger; Oliver Eickelberg
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

7.  Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.

Authors:  Tomonori Makiguchi; Mitsuhiro Yamada; Yusuke Yoshioka; Hisatoshi Sugiura; Akira Koarai; Shigeki Chiba; Naoya Fujino; Yutaka Tojo; Chiharu Ota; Hiroshi Kubo; Seiichi Kobayashi; Masaru Yanai; Sanae Shimura; Takahiro Ochiya; Masakazu Ichinose
Journal:  Respir Res       Date:  2016-09-05

8.  Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.

Authors:  Mareike Lehmann; Martina Korfei; Kathrin Mutze; Stephan Klee; Wioletta Skronska-Wasek; Hani N Alsafadi; Chiharu Ota; Rita Costa; Herbert B Schiller; Michael Lindner; Darcy E Wagner; Andreas Günther; Melanie Königshoff
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

9.  Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis.

Authors:  Ting Xie; Yizhou Wang; Nan Deng; Guanling Huang; Forough Taghavifar; Yan Geng; Ningshan Liu; Vrishika Kulur; Changfu Yao; Peter Chen; Zhengqiu Liu; Barry Stripp; Jie Tang; Jiurong Liang; Paul W Noble; Dianhua Jiang
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

10.  Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice.

Authors:  Laura A Hancock; Corinne E Hennessy; George M Solomon; Evgenia Dobrinskikh; Alani Estrella; Naoko Hara; David B Hill; William J Kissner; Matthew R Markovetz; Diane E Grove Villalon; Matthew E Voss; Guillermo J Tearney; Kate S Carroll; Yunlong Shi; Marvin I Schwarz; William R Thelin; Steven M Rowe; Ivana V Yang; Christopher M Evans; David A Schwartz
Journal:  Nat Commun       Date:  2018-12-18       Impact factor: 14.919

View more
  21 in total

1.  WNT Signalling in Lung Physiology and Pathology.

Authors:  Yan Hu; Chiara Ciminieri; Qianjiang Hu; Mareike Lehmann; Melanie Königshoff; Reinoud Gosens
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

3.  Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects against Pulmonary Fibrosis.

Authors:  Irina G Luzina; Violeta Rus; Virginia Lockatell; Jean-Paul Courneya; Brian S Hampton; Rita Fishelevich; Alexander V Misharin; Nevins W Todd; Tudor C Badea; Horea Rus; Sergei P Atamas
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 7.748

4.  Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis.

Authors:  Antonia Charchanti; Panagiotis Kanavaros; Efthymios Koniaris; Agapi Kataki; Georgios Glantzounis; Niki J Agnantis; Anna C Goussia
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

5.  Genetic Signatures of Acute Asthma Exacerbation Related With Ineffective Response to Corticosteroid.

Authors:  Min Gyu Kang; Hyun Seung Lee; Kelan G Tantisira; Heung Woo Park
Journal:  Allergy Asthma Immunol Res       Date:  2020-07       Impact factor: 5.764

Review 6.  Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases.

Authors:  Abdulrahman Ibrahim; Ahmed Ibrahim; Tanyalak Parimon
Journal:  Diagnostics (Basel)       Date:  2021-01-07

7.  Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan; Rasel Ahmed; Md Sabbir Hossain; Shah Md Tamim Kabir; Md Shahidul Islam; A M A M Zonaed Siddiki
Journal:  J Transl Med       Date:  2021-01-07       Impact factor: 5.531

8.  Categorization of lung mesenchymal cells in development and fibrosis.

Authors:  Xue Liu; Simon C Rowan; Jiurong Liang; Changfu Yao; Guanling Huang; Nan Deng; Ting Xie; Di Wu; Yizhou Wang; Ankita Burman; Tanyalak Parimon; Zea Borok; Peter Chen; William C Parks; Cory M Hogaboam; S Samuel Weigt; John Belperio; Barry R Stripp; Paul W Noble; Dianhua Jiang
Journal:  iScience       Date:  2021-05-19

Review 9.  Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics.

Authors:  David R Brigstock
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

Review 10.  Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis.

Authors:  Tanyalak Parimon; Changfu Yao; Barry R Stripp; Paul W Noble; Peter Chen
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.